Prenetics Global (NASDAQ:PRENW – Get Free Report) is expected to issue its resultson Thursday, May 14th. Analysts expect the company to announce earnings of ($0.8225) per share and revenue of $37.9030 million for the quarter.
Prenetics Global Price Performance
Prenetics Global stock opened at $0.02 on Tuesday. The company’s 50 day simple moving average is $0.02 and its 200 day simple moving average is $0.02. Prenetics Global has a fifty-two week low of $0.01 and a fifty-two week high of $0.07.
About Prenetics Global
Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.
Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.
Featured Stories
- Five stocks we like better than Prenetics Global
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
